Skinvisible, Inc.
SKVI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,706 | $380 | $459 | $1,090 |
| - Cash | $10 | $1 | $81 | $66 |
| + Debt | $5,738 | $6,153 | $3,716 | $3,083 |
| Enterprise Value | $7,433 | $6,532 | $4,094 | $4,107 |
| Revenue | $20 | $20 | $279 | $663 |
| % Growth | 0% | -92.8% | -57.9% | – |
| Gross Profit | -$0 | $20 | $274 | $660 |
| % Margin | -2.2% | 100% | 98.3% | 99.5% |
| EBITDA | $124 | -$477 | -$43 | $206 |
| % Margin | 621.1% | -2,382.6% | -15.5% | 31.1% |
| Net Income | -$566 | -$2,382 | -$2,211 | -$2,286 |
| % Margin | -2,828.3% | -11,912.2% | -791.8% | -344.5% |
| EPS Diluted | -0.11 | -0.52 | -0.49 | -0.5 |
| % Growth | 78.8% | -6.1% | 2% | – |
| Operating Cash Flow | -$70 | -$77 | $45 | $375 |
| Capital Expenditures | -$9 | -$9 | -$3 | -$21 |
| Free Cash Flow | -$79 | -$86 | $43 | $354 |